ABSTRACT: A novel one-step approach for designing non aggregated silica-based mesostructured therapeutic vectors is presented. Evaporation Induced Self Assembly was used in combination with amphiphilic drugs for preparing already loaded class I and class II hybrid materials containing from 50 to 60 wt% (up to 75 vol%) of drug. A good mesostructuration was able to promote an interfacial control of the drug release in PBS medium with a complete absence of the initial burst release very often described in literature for water soluble drug release experiments. The investigation of both release mechanisms and matrix dissolution was conducted via in situ ellipsometry and NMR. It proved that the nature of the drug/matrix interaction, the chemical composition of the drug/matrix interface, as well as the mesostructuration quality parameters must be taken into account at the same time for tuning the drug release rate, while maintaining the dissolution rate of silica at a reasonable level for limiting its toxicity. It proved also that non-calcined as made silica-based class I hybrid materials can be efficiently used for tuning drug release kinetics from one hour to day scale.
INTRODUCTION
The design of nanomaterials for drug transport and controlled release is a matter of utmost importance in biomedical science. Such therapeutic vectors, developed and tested in the last ten years, are aimed for accumulating in diseased tissues and deliver drug molecules at a tunable rate (Gref 1994 Higher drug loads are usually achieved within highly porous silica carriers presenting mesopores larger than 4 nm. However, this method leads to a part of the drug molecules adsorbed onto their internal surface, and to another part weakly entrapped at the heart of mesopores. These latter are rapidly released by diffusion and cause an initial burst of drug release which is difficult to control (Song Langmuir 2005) . In order to maintain high drug loads and to avoid the presence of these weakly bound molecules which release is hard to control, the mesopores size has to be finely tuned for each specific drug, which obliges materials scientist to design and optimize a specific inorganic vector for each drug (Horcajada 2004 ).
Building a system in which a molecule is at the same time the structuring agent and the therapeutic agent represents an original approach in this field for it would allow the direct mesostructuration and encapsulating of high loads of drug, while insuring that each drug molecules interact in a similar way with the silica-based matrix.
If the drug displays amphiphilic character, uncontrolled phase separation during sol-gel encapsulation can be avoided and the homogeneity of the material at the nanoscale is ensured by controlled nanosize separation of drug micelles within the inorganic or hybrid network. The three main advantages of this strategy are the following: (i) a much simpler one step synthesis method in which no calcination and no post drug loading is required (obviously favorable in terms of atom economy), (ii) high drug loading can be achieved (more than 50 vol % according to usual syntheses of mesostructured silica with common structuring agents such as CTAB or nonionic surfactants), which decreases the amount of inorganic matrix in proportion, contributing to decrease its intrinsic toxicity , (iii) each drug molecule should interact in a similar manner with the silica-based wall. The release kinetic is thus in principle very easily tunable by modulating the drug-wall interaction and the degradation rate of the matrix. In this work, we investigated the validity of this concept by using three types of amphiphilic drug molecules: stearoyl choline iodide (SC), glucosyl resveratrol (GR) and sophorolipids (SL).
Choline esters were shown to be potentially useful for the treatment of Alzheimer disease (Brevet Patel 2005, Alcaro 2010). Resveratrol is a natural molecule contained in red wine and may be related with the decrease in coronary heart disease observed among wine drinkers (French paradox) (Frémont 2000) . Glycosylation of resveratrol protects it from enzymatic oxidation, increases its absorption and thus extends its lifetime in the cell (Scholz, 1998) , and confirmed in more recent studies, sophorolipids influence the growth and apoptosis of H7402 human liver cancer cells (Chen, 2006) . Their selfassembling properties have been previously investigated in (Baccile 2010 ) and (Baccile 2012 ). These molecules have surfactant properties (Figure 1 ) and were used in the present work for synthetizing mesostructured silica or class II hybrid materials by Evaporation Induced Self Assembly (EISA). For comparing the properties of mesostructured materials made out of those molecules, we prepared both particles and films by evaporation Induced Self Assembly (EISA) (particles were made through aerosol route, and thin films were made by dipcoating) (Brinker 1999 , Boissiere 2011 . Thin films were used as model systems for monitoring precisely by in situ ellipsometry the drug release and the degradation kinetics of the sol-gel matrix in undersaturation conditions of silica. Thanks to the low amount of matter involved with thin films experiments, we avoided the silica saturation and renucleation of silica particles or gel network detrimental for the comparison of the different drug systems investigated (details of the experimental protocol is described in the reference Fontecave 2012).
EXPERIMENTAL SECTION
Sophorolipids synthesis. In this work we used the open acidic form of sophorolipids, as shown in Figure 1 . The detailed synthesis of these compounds was described in a previous work [Baccile et al., Green Chem., 2010] .
Glucosyl-Resveratrol biosynthesis:
A mix of (3-OH)-α-glucosylated resveratrol and (4'-OH)-α-glucosylated resveratrol was synthesized by scaling-up the enzymatic reaction described in reference (Torres 2011 ). Thin films were made by sol-gel process. Initial sol compositions are described in the table 1. The sols were coated on silicon wafers by dip-coating, at a constant rate of 6 mm.s -1 , in a 40% relative humidity atmosphere.
Right after withdrawal, the sample is exposed to a 75% relative humidity atmosphere for 5 minutes. 
Aerosol-made particles synthesis:
Initial sol compositions are described in table 1. For stearoyl chloline and sophorolipids, the home-made aerosol apparatus described in reference (Julian-Lopez 2007) was used. Briefly, droplets are generated by a TSI-6 jet atomizer. They are led by an air flow through 50 cm-long 250°C-heated quartz tube in which they stay a few seconds. Resulting solid particles were collected with a PTFE filter. For glucosyl-resveratrol, a low-temperature aerosol process was developed. The aerosol is generated from the sol and led by dry air to a 3 meter long -0.6 cm large -helical glass tube. The tube is thermostated at 60°C thanks to circulating warm oil. Before collection, the aerosol is bubbled in a 0.25 mol.L -1 solution of ammonia in water in order to improve the condensation of the outer silica part of the particles, so that the particles do not stick one to another onto the filter. Characterizations. Grazing Incidence Small-Angle X-ray Scattering (GI-SAXS) was recorded using a Rigaku S-MAX 3000. Spectroscopic ellipsometry and Environmental Ellipsometric Porosimetry analyses were recorded with a M2000 Woolam ellipsometer equipped with a controlled atmosphere cell in which relative humidity was controlled by mass flow controllers (the setup and analysis protocol are described in reference Boissiere 2005).
The analysis beam incidence angle was fixed at 70°. The modeling of the deposited sol-gel layers was performed with a simple Cauchy model. Transmission electron microscopy (TEM) was carried out using a JEOL 100 CX II microscope. TEM micrographs were processed with a slow scan CCD camera and analyzed with the Digital
Micrograph program
Degradation study. A dedicated in-situ ellipsometric analysis cell was developed for the degradation study.
Briefly, the aim of this analysis being to directly monitor the degradation kinetic of mesoporous model layers in simulated biological medium, we built a double layer liquid cell containing 50 mL of PBS medium. The PBS temperature was controlled and maintained by liquid circulation of hot water within the walls of the liquid cell via an external thermostatic circulation pump. Two non-birefringent windows were adapted for allowing the light beam of the ellipsometer to pass. The real temperature of PBS was controlled by a thermocouple. For each experiment, the 1 cm 2 film was introduced into the chamber after thermal equilibration and analysed automatically every 60 seconds. In order to monitor silica dissolution, the volume fraction of silica was computed at each time of the analysis. At each time, a system of three equations with three unknowns was resolved. The three unknowns are f SiO 2 (t), f Drug (t) and f H 2 O (t) which are the volume fractions of silica, Glucosyl-Resveratrol and water, respectively. The three equations are:
where BEMA is the Bruggeman Effective Medium Approximation, n(t) is the refractive index of the thin film measured by ellipsometry and nf Drug (t) is the normalized molar fraction of drug released, measured by in situ UV spectroscopy. The refractive index of the drug was computed with a standard Bruggemann Effective Medium
Approximation between drug and silica, considering that the volume fraction could be deduced from the mass fraction and the densities of each component of the films. A dense silica film was made with the same lowtemperature thermal treatment for determining the refractive index of silica in the class I hybrid thin film. The variations of thickness were then considered to compute the remaining silica quantity, at each time.
RESULTS

Structuration by Stearoyl Choline
Stearoyl The templating efficiency of SC is thus very high. The same process of structuration by EISA was used for preparing mesostructured particles by spray drying. The spherical nanosize particles obtained exhibited a worm like type mesostructure (Fig 2) . The drug loading, directly controlled by the initial SC/TEOS molar ratio of the solution is, in this case, fairly high (60 wt%) if compared with drugs post impregnation in mesostructured materials of similar pore size (Vallet-Regi 2007 Angewandte) . If we assume that this drug behaves in a similar way than CTAB surfactant, the theoretical maximum load of such a vector (according to the maximum CTAB/Si molar ratio at which a mesostructure is reported by spray drying processing in literature) could be as high as 73wt %. After calcination of the powder, the narrow pore size distribution observed by nitrogen physisorption analysis ( Fig. 2C and SI 3) proved that SC still efficiently templates silica matrix as expected. As a consequence, the concept of direct drug templating is valid for making therapeutic silica-based nanovectors. (due to the presence of a significant amount of ethanol in the solution and dry air) than in film formation, the silica/GR seems to achieve mesostructuration only under slow evaporation conditions. As a conclusion, if the efficient encapsulation of high amount of GR is possible by EISA, the efficacy of using Glucosyl-Resveratrol 
Drug release and degradation of thin films
To compare drug release rates of different films produced in this study, we used Hill's equation with good accuracy (results given in table 2). From these data we could simply analyse the various parameters and interdependencies of the drug/matrix/interaction/structuration system and extract the critical parameters. Glucosyl-Resveratrol and Sophorolipids have the same type of hydrophilic glucose derivated head. They interact with the silica surface through hydrogen bonding. However, the SL release in PBS (pH=7.4) is about two times slower than GR release. It appears clearly that the mesostructuration quality has a strong impact on both drug release profile and kinetics (Fig. 5) . The presence of aggregates in the GR-SiO 2 architecture (evidences by the broad pore size distribution obtained from physisorption isotherms of powder and film) promotes an irregular release profile characterized by first bursts of GR release, followed by a more regular release profile that can be fitted by a standard Hill's equation. Conversely, SL was shown to have a well-structured vermicular network promoting narrow domains size distribution within the silica matrix. In such a case, each SL molecule a priori interacts directly with the silica walls. It is remarkable to observe that the slower and more controlled SL release resulting only from the nanostructuration homogeneity can be observed for such a high drug loading (51 wt%).
2) Drug/material interaction impacts drug release rates.
Sophorolipid and Stearoyl-Choline templated silica thin films have the same type of cylindrical drug networks.
In both cases, the great majority of drug molecules are in direct interaction with the inorganic surface. However, the type of interaction between drug and silica is completely different in each case. In the case of SL, the sugar moiety is very likely to interact with the inorganic matrix by hydrogen bonding. In the case of SC, at pH=7.4 a strong electrostatic interaction exists between the positively charged quaternary ammonium head of the molecules and the negatively charged silanolate groups of the surface. This interaction leads to extremely slow drug release, with a half-time of 5 hours, and a total release after two days. Although not surprising, the strong impact of the drug/matrix interaction onto the release time is very interesting because it allows day scale release times with poorly condensed (non calcined) silica network, proving that the direct-drug-templating approach is a robust method for tailoring silica-based vectors with controlled dissolution/release kinetics.
3) Drug/material composition impacts drug release rates By looking at the pure silica/SL system, one sees that half-times of silica dissolution and drug release have the same Hill's equation release profile, suggesting that the progressive dissolution of the matrix is partially responsible for the SL release. Such a silica dissolution profile contrasts a lot with the linear dissolution profiles observed on pure mesoporous silica materials, proving that the drug/matrix interaction and/or the film composition and structure strongly impact the vector dissolution profile (Fontecave 2012) . As already demonstrated in the same reference, the 30% methylated hybrid silica matrix being one order of magnitude slower than that of SL-TEOS. Although the interaction between SL and the 30% mol methylated matrix can be expected to be weaker, the SL release from SL-MTEOS30 is also found slower (by about 35%) than from SL-TEOS, while still exhibiting a regular release profile as expected from a drug-mesostructured material with a narrow drug domains size distribution (SI 2). As a consequence, the drug/material interaction is not the only parameter influencing the drug release. If now one compares the evolution of the film thicknesses versus time in PBS, one realises that drug release mechanisms are more complex than "simple" diffusion-limited and/or dissolution assisted mechanisms (Fig. 6) . Indeed, the soaking in PBS medium promotes the swelling of the SL-based films while SC-based film thickness decreases with time.
This strongly suggests that water molecules diffuse within SL-based films via the large silica/sophorose interphase which is able to dissolve high amount of water molecules. In a previous work, we have shown that the SL micelle/H 2 O interface is constituted by 90% of water (Baccile 2012 ). Under such conditions, water molecules are likely to be good competitors for sophorose/silanolates hydrogen bonds and thus to promote the fast release of sophorolipid molecules (Fig. 7) . Such mechanism is coherent with the fact that the methylation of 30% of silica centres slows down the swelling of the film (thus the amount of water diffusing at the SL/silica interface) and slows down the release of sophorolipids molecules. A similar mechanism is probably responsible for the fast release of many hydrophilic species adsorbed within mesoporous silica materials in literature (captopril (Qu hydrophilic Stearoylcholine/silica interface which is much narrower and less eager for water molecules does not facilitate their diffusion within the film (Baccile 2007 ). The progressive decrease of thickness suggests that the drug release mechanism at stake here is more related with a classical desorption of SC, probably followed by diffusion-triggered rearrangement of SC within the silica network. In such conditions, the dissolution of silica is slow at short time (dissolution at the external surface of the material) and progressively quickens as more internal surface is available for water. From the comparison of both systems, we learnt that if the strength of the drug/matrix interaction plays a major role in the drug release kinetic, strong modulations can be observed if water can diffuse and compete with it.
In this work, we proved that EISA strategy was a simple, fast and efficient process for producing silica-based particles directly mesostructured by amphiphilic therapeutic molecules. In this context, many biologically active compounds (vitamins, hormones, flavonoids, antibiotics, etc.) contain glycosidic moieties and exhibit surfactant properties.When prepared by spray drying, already loaded and non-aggregated spherical particles were obtained in one step. Very high drug loads could be obtained (up to 60 wt% in this work) while maintaining sophorolipids and stearoyl choline structuring agents in monodisperse micellar domains periodically organized within the silica matrix. Even if the periodicity of the matrix is not necessarily the goal one should aim for in vectorization application, in this case it was shown to be a good quality criteria for promoting at the same time high amphiphilic drug loading an homogeneous drug/matrix interaction. This constitutes a strong improvement if compared with conventional silica-based mesoporous vectors that can hardly achieve both high loading and homogeneous drug/matrix interaction (Azais 2006). In addition, reaching very high drug loading impacts positively the global toxicity of the vector because much less inorganic material is used for their constitution. In parallel, we studied in situ both drug release kinetic and matrix dissolution in PBS medium. For that, drugtemplated films of similar composition were prepared by EISA. By coupling ellipsometry investigations and NMR analysis of PBS solution versus time, we could decorrelate silica dissolution and drug release and studied the influences and interdependency of the matrix mesostructure, structure and composition onto dissolution and release kinetics. We proved that a good mesostructuration quality coupled with the drug-templating approach (thus homogeneous drug/silica interaction) is able to eliminate completely the initial burst release very often described in literature in release experiments of water soluble drugs. In a similar way than with class II hybrid mesoporous silica, we showed that non covalent drug/silica interactions of such mesostructured class I hybrid material could present a wide range of release kinetics, from minutes in the case of sugar-based hydrophilic head interacting with silica-based surfaces, to hours, in the case of strong electrostatic interaction. Both release and dissolution kinetics were found impacted by the structuring capacity of the drug, the capacity of the organic/inorganic interface to solubilize water and the composition of the matrix proving that the controlled design of a therapeutic vector has to be considered globally for tuning the drug release rate and the dissolution kinetic of the matrix.
The direct drug templating approach presented here can be generalized to hydrophilic drug which can be functionalized with hydrophobic tails. Resulting molecules can have self-assembly properties (Couvreur 2008) and are also potential candidates for this novel strategy. Hydrophobic drugs are compatible with this approach as well. They can be solvated in the hydrophobic cores of bio-compatible surfactant micelles during the EISA process (Fatnassi 2010) . Combined with the easy elaboration of class II hybrid materials and nano-composites by EISA, the direct drug templating is likely to promote in the near future a better method for mastering and tuning at the same time the complexity of drug/material interaction in liquid biological medium, and the intrinsic stability of the matrix that must be tuned for limiting its toxicity.
